Immunocompetent human 3D liver model to accelerate AAV-based ATMP development

Authors

• Paula Alves, iBET, ITQB NOVA, Portugal
• Catarina Brito, ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa and iBET - Instituto de Biologia Experimental e TecnológicaFollow
• Francisca Arez, iBET and ITQB NOVA
• Isabella Ramella Gal, iBET and ITQB NOVA
• Giacomo Domenici, iBET and ITQB NOVA
• Sofia Fernandes, iBET and ITQB NOVA
• Inês Correia, iBET and ITQB NOVA
• Gabriela Silva, iBET and ITQB NOVA
• Nádia Duarte, iBET and ITQB NOVA
• Catarina Freitas, iBET and ITQB NOVA
• A S Coroadinha, iBET and ITQB NOVA
• Udo Maier, Boehringer Ingelheim Pharma GmbH & Co. KG
• Francois du Plessis, Boehringer Ingelheim Pharma GmbH & Co. KG

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Paula Alves, Catarina Brito, Francisca Arez, Isabella Ramella Gal, Giacomo Domenici, Sofia Fernandes, Inês Correia, Gabriela Silva, Nádia Duarte, Catarina Freitas, A S Coroadinha, Udo Maier, and Francois du Plessis, "Immunocompetent human 3D liver model to accelerate AAV-based ATMP development" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/207